tiprankstipranks
Monte Rosa Therapeutics (GLUE)
NASDAQ:GLUE
US Market

Monte Rosa Therapeutics (GLUE) Technical Analysis

56 Followers

Technical Sentiment

Overall Consensus
Strong Buy
16Bullish
4Neutral
2Bearish
Technical Analysis Consensus
Buy
4Bullish
4Neutral
2Bearish
Moving Average Consensus
Strong Buy
12Bullish
0Neutral
0Bearish
Monte Rosa Therapeutics’s (GLUE) Moving Averages Convergence Divergence (MACD) indicator is -0.05, suggesting Monte Rosa Therapeutics is a Sell.
Monte Rosa Therapeutics’s (GLUE) 20-Day exponential moving average is 5.15, while Monte Rosa Therapeutics’s (GLUE) share price is $5.96, making it a Buy.
Monte Rosa Therapeutics’s (GLUE) 50-Day exponential moving average is 5.08, while Monte Rosa Therapeutics’s (GLUE) share price is $5.96, making it a Buy.

Monte Rosa Therapeutics (GLUE) Pivot Points

Feb 21, 2024, 01:31 PM
Name
S3
S2
S1
Pivot Points
R1
R2
R3
Classic
4.48
4.69
5.11
5.33
5.75
5.97
6.39
Fibonacci
4.69
4.94
5.09
5.33
5.57
5.72
5.97
Pivot points are a technical analysis tool used by traders to identify potential support and resistance levels in financial markets. Pivot points are calculated based on the previous day's high, low, and close prices, and are used to help traders identify levels at which the price may reverse or continue to trend.

Monte Rosa Therapeutics (GLUE) Moving Averages

Feb 21, 2024, 01:31 PM
Period
Simple
Exponential
MA5
5.03Buy
5.29Buy
MA10
4.92Buy
5.12Buy
MA20
5.16Buy
5.15Buy
MA50
5.30Buy
5.08Buy
MA100
4.49Buy
5.04Buy
MA200
5.49Buy
5.61Buy
Monte Rosa Therapeutics’s (GLUE) 10-Day exponential moving average is 5.12, while Monte Rosa Therapeutics’s (GLUE) share price is $5.96, making it a Buy.
Monte Rosa Therapeutics’s (GLUE) 100-Day exponential moving average is 5.04, while Monte Rosa Therapeutics’s (GLUE) share price is $5.96, making it a Buy.
Monte Rosa Therapeutics’s (GLUE) stock price is $5.96 and Monte Rosa Therapeutics’s (GLUE) 50-day simple moving average is 5.30, creating a Buy signal.
Monte Rosa Therapeutics’s (GLUE) stock price is $5.96 and Monte Rosa Therapeutics’s (GLUE) 100-day simple moving average is 4.49, creating a Buy signal.
Monte Rosa Therapeutics’s (GLUE) stock price is $5.96 and Monte Rosa Therapeutics’s (GLUE) 200-day simple moving average is 5.49, creating a Buy signal.

Monte Rosa Therapeutics (GLUE) Technical Indicators

Feb 21, 2024, 01:31 PM
Name
Value
Implied Action
RSI (14)
58.88
Neutral
STOCH (9,6)
78.48
Neutral
STOCHRSI (14)
60.37
Neutral
MACD (12,26)
-0.05
Sell
ADX (14)
18.36
Buy
Williams %R
-25.26
Buy
CCI (14)
138.99
Sell
ATR (14)
0.55
-
Ultimate Oscillator
55.79
Neutral
ROC
1.36
Buy
Monte Rosa Therapeutics’s (GLUE) Relative Strength Index (RSI) is 58.88, creating a Neutral signal.
Monte Rosa Therapeutics’s (GLUE) Trend Strength Indicator (ADX) is 18.36, creating a Buy signal.
Monte Rosa Therapeutics’s (GLUE) Commodity Channel Index (CCI) is 138.99, creating a Sell signal.
Monte Rosa Therapeutics’s (GLUE) Price Rate of Change (ROC) is 1.36, creating a Buy signal.

FAQ

Is GLUE a Buy, Hold, or Sell?
Based on GLUE’s technical indicators, GLUE is a Strong Buy.
    What is GLUE’s RSI (14)?
    GLUE’s RSI (14) is 58.88, which suggests GLUE is a Neutral.
      What is GLUE’s MACD?
      GLUE’s MACD is -0.05, which suggests GLUE is a Sell.
        What is GLUE’s 5-day moving average?
        GLUE’s 5-day moving average is 5.03, which suggests GLUE is a Buy.
          What is GLUE’s 20-day moving average?
          GLUE 20-day moving average is 5.16, which suggests GLUE is a Buy.
            What is GLUE’s 50-day moving average?
            GLUE’s 50-day moving average is 5.30, which suggests GLUE is a Buy.
              What is GLUE’s 200-day moving average?
              GLUE’s 200-day moving average is 5.49, which suggests GLUE is a Buy.
                What is GLUE’s Williams % R (14)?
                GLUE’s Williams % R (14) is -25.26, which suggests GLUE is a Buy.
                  What is GLUE’s CCI (14)?
                  GLUE’s CCI (14) is 138.99, which suggests GLUE is a Sell.
                    What's Included in PREMIUM?
                    Make informed decisions based on Top Analysts' activity
                    Know what industry insiders are buying
                    Get actionable alerts from top Wall Street Analysts
                    Find out before anyone else which stock is going to shoot up
                    Get powerful stock screeners & detailed portfolio analysis